Public Biotechnology Company Buys Cancer Vaccine Domain Names
Lend.me

Public Biotechnology Company Buys Cancer Vaccine Domain Names

8

In the most recent DNJournal weekly domain sales report, Ron Jackson reported the sale of two cancer vaccine domain names: CancerVaccine.org sold for $18,000 and CancerVaccine.net sold for $10,000. According to the updated Whois records for both domain names, the company that acquired them is a publicly traded pharmaceutical company called Northwest Biotherapeutics (Stock symbol: NWBO).

Additional research led me to find that the company also acquired CancerVaccine.com as well. Up until August 1, the domain name was owned under privacy protection at Moniker, but the Whois lookup is now showing that it is owned by Northwest Biotherapeutics at Go Daddy. Prior to its privacy protection in late 2012, it was owned by a domain investor in New Jersey. It is possible the company had owned it at that point, and the privacy was removed after the transfer.

At the moment, it does not appear that the domain names are being utilized by the company.

I did a bit of cursory research on Northwest Biotherapeutics, and on the company’s website, it mentions this: “The Company’s platform technology, DCVax®, uses a patient’s own dendritic cells, the starter engine of the immune system. The dendritic cells are extracted from the body, loaded with tumor biomarkers or ‘‘antigens’’, thereby creating a personalized therapeutic vaccine.”

It’s a wise move for NWBO to own these particular domain names because it’s more likely that people will remember the words “cancer vaccine” rather than the company or product name. I am not familiar with pharmaceutical marketing, but I assume that they could use these generic domain names in marketing materials, making it easier for patients and medical professionals to remember how to navigate to the company website, assuming they plan to use these domain names in market.

Congratulations to Northwest Biotherapeutics for getting these important domain names.


About The Author: Elliot Silver is an Internet entrepreneur and his company earns revenue from domain names. Elliot is President of Top Notch Domains, LLC, a company that has sold seven figures worth of domain names in the last five years. Elliot is the publisher of DomainInvesting.com. Read this blog's disclaimer for information about the publisher, comment policy, disclosures, and conflicts.

Reach out to Elliot: Twitter | | Facebook | Email
Niche Websites

Comments (8)

    Adi Weitzman

    I find it interesting that the .org sold for more than the .net.

    August 8th, 2013 at 3:16 pm

      Elliot Silver

      Most likely different owners meant different prices. Personally, I like the .org more than the .net here, and in general, I’d probably choose a .org over a .net if the .org made sense. I have no interest in .net.

      August 8th, 2013 at 3:17 pm

      Adi Weitzman

      Couldn’t agree more. The .org works so much better than the .net here.

      August 8th, 2013 at 3:30 pm

      Mark

      Here it is because the .org represents this company much better

      August 9th, 2013 at 5:00 am

    John

    There are a bunch of vaccine biotech companies out there. I remember trading in and out of this one years ago. If my memory serves correct they did a reverse split years ago. Hopefully, that whole sector will be able to get some breakthroughs in the near future for the disease. Nice story.

    August 8th, 2013 at 3:25 pm

    Andrew hyde

    I like the .org’s better than the .net’s and just sold a two word eight char .org for 25k today…

    August 29th, 2013 at 4:15 pm

    Dr. John Najarian

    I’ve heard of this company purchasing. Very cutting edge science they have.

    November 24th, 2013 at 12:52 pm

    Andrew

    I have Curable.org up for a quick sale now

    November 24th, 2013 at 1:22 pm

Leave a Reply

Name *

Mail *

Website